# ZILRETTA in Subjects With Shoulder Osteoarthritis

> **NCT06269705** · PHASE3 · RECRUITING · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 150 (estimated)

## Conditions studied

- Glenohumeral Osteoarthritis

## Interventions

- **DRUG:** ZILRETTA
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06269705
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-05
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06269705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06269705, "ZILRETTA in Subjects With Shoulder Osteoarthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06269705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*